COMPLEMENT-MEDIATED KIDNEY DISEASE

Clinical trials for COMPLEMENT-MEDIATED KIDNEY DISEASE explained in plain language.

Never miss a new study

Get alerted when new COMPLEMENT-MEDIATED KIDNEY DISEASE trials appear

Sign up with your email to follow new studies for COMPLEMENT-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New drug trial targets rare kidney diseases

Disease control Recruiting now

This study is testing an experimental drug called ADX-038 for people with specific immune-related kidney diseases. Researchers will enroll 45 adults with conditions like IgA nephropathy or C3 glomerulopathy to see if the drug is safe and helps control their kidney disease. The go…

Matched conditions: COMPLEMENT-MEDIATED KIDNEY DISEASE

Phase: PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

COMPLEMENT-MEDIATED KIDNEY DISEASE

Get alerted when new COMPLEMENT-MEDIATED KIDNEY DISEASE trials appear

New drug trial targets rare kidney diseases